PRS-344
- Generic Name
- PRS-344
A Study of PRS-344/S095012 (PD-L1x4-1BB Bispecific Antibody-Anticalin Fusion) in Patients With Solid Tumors
- First Posted Date
- 2021-12-16
- Last Posted Date
- 2025-05-13
- Lead Sponsor
- Servier Bio-Innovation LLC
- Target Recruit Count
- 45
- Registration Number
- NCT05159388
- Locations
- 🇪🇸
Hospital Universitario Gregorio, Madrid, Spain
🇦🇺Chris O'Brian Lifehouse, Camperdown, Australia
🇪🇸START, Madrid, Spain
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath